Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Barry

Showing results (651-660 of 674) with videos related to

Pageof 68
Sort By:
Congestive Heart Failure (Greenwich, Conn.)|April 3, 2002
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 4--treatmentCarl V Leier, Marc A Silver, Michael W Rich, et al.
Nature Communications|June 9, 2021
Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesisJoshua D G Leach, Nikola Vlahov, Petros Tsantoulis, et al.
Science Translational Medicine|August 17, 2018
TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescenceThomas G Bird, Miryam Müller, Luke Boulter, et al.
Nature Cell Biology|November 13, 2024
Hepatocellular senescence induces multi-organ senescence and dysfunction via TGFβChristos Kiourtis, Maria Terradas-Terradas, Lucy M Gee, et al.
Cancer Cell|July 11, 2025
KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancerAna Galan-Cobo, Natalie I Vokes, Yu Qian, et al.
Cancer Discovery|March 8, 2024
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug CombinationsAzadeh C Bashi, Elizabeth A Coker, Krishna C Bulusu, et al.
Cancer Research|September 19, 2023
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor ResistanceMandy Lawson, Natalie Cureton, Susana Ros, et al.
Nature|January 7, 2016
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancerShaokun Shu, Charles Y Lin, Housheng Hansen He, et al.
Nature Communications|December 8, 2022
Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive featuresDustin J Flanagan, Raheleh Amirkhah, David F Vincent, et al.
Nature Communications|January 31, 2023
Author Correction: Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive featuresDustin J Flanagan, Raheleh Amirkhah, David F Vincent, et al.
Pageof 68

Showing results (651-660 of 674) with videos related to

Sort By:
Pageof 68
Congestive Heart Failure (Greenwich, Conn.)|April 3, 2002
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 4--treatmentCarl V Leier, Marc A Silver, Michael W Rich, et al.
Nature Communications|June 9, 2021
Oncogenic BRAF, unrestrained by TGFβ-receptor signalling, drives right-sided colonic tumorigenesisJoshua D G Leach, Nikola Vlahov, Petros Tsantoulis, et al.
Science Translational Medicine|August 17, 2018
TGFβ inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescenceThomas G Bird, Miryam Müller, Luke Boulter, et al.
Nature Cell Biology|November 13, 2024
Hepatocellular senescence induces multi-organ senescence and dysfunction via TGFβChristos Kiourtis, Maria Terradas-Terradas, Lucy M Gee, et al.
Cancer Cell|July 11, 2025
KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancerAna Galan-Cobo, Natalie I Vokes, Yu Qian, et al.
Cancer Discovery|March 8, 2024
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug CombinationsAzadeh C Bashi, Elizabeth A Coker, Krishna C Bulusu, et al.
Cancer Research|September 19, 2023
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor ResistanceMandy Lawson, Natalie Cureton, Susana Ros, et al.
Nature|January 7, 2016
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancerShaokun Shu, Charles Y Lin, Housheng Hansen He, et al.
Nature Communications|December 8, 2022
Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive featuresDustin J Flanagan, Raheleh Amirkhah, David F Vincent, et al.
Nature Communications|January 31, 2023
Author Correction: Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive featuresDustin J Flanagan, Raheleh Amirkhah, David F Vincent, et al.
Pageof 68